Guangdong Kanghua Healthcare Group Co., Ltd. (HKG:3689)
Hong Kong · Delayed Price · Currency is HKD 1.900
0.00 (0.00%)
Aug 26, 2026, 9:40 AM HKT
HKG:3689 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,980 | 2,024 | 2,056 | 2,042 | 1,846 | 1,954 | |
Revenue Growth | -3.53% | -1.53% | 0.68% | 10.63% | -5.54% | 11.97% |
Cost of Revenue | 1,612 | 1,655 | 1,734 | 1,677 | 1,600 | 1,629 |
Gross Profit | 368.5 | 368.92 | 321.87 | 364.37 | 245.15 | 325.05 |
Selling, General & Admin | 201 | 207.43 | 277.1 | 242.39 | 212.12 | 174.32 |
Operating Expenses | 207.55 | 221.49 | 281.49 | 245.1 | 215.91 | 199.03 |
Operating Income | 160.95 | 147.43 | 40.39 | 119.27 | 29.24 | 126.02 |
Interest Expense | -18.15 | -15.96 | -11.95 | -9.41 | -15.04 | -19.81 |
Interest & Investment Income | 10.29 | 10.29 | 13.8 | 17.01 | 16.51 | 10.48 |
Earnings From Equity Investments | -4.8 | -23.16 | - | - | - | - |
Currency Exchange Gain (Loss) | -3.42 | -3.42 | 2.5 | 1.13 | 5.91 | -2.29 |
Other Non Operating Income (Expenses) | -6.03 | 4.12 | 39.73 | 26.5 | 30.31 | 33.11 |
EBT Excluding Unusual Items | 138.83 | 119.3 | 84.47 | 154.5 | 66.93 | 147.5 |
Impairment of Goodwill | - | - | - | - | - | -15.51 |
Gain (Loss) on Sale of Investments | 8.6 | 8.6 | -9.4 | -0.88 | -4.44 | -2.33 |
Gain (Loss) on Sale of Assets | 7.86 | 18.54 | -0.35 | -0.19 | -0.58 | -0.45 |
Asset Writedown | -17.92 | -4.5 | - | - | - | - |
Other Unusual Items | 0.36 | 0.36 | -11.67 | - | 7.4 | - |
Pretax Income | 137.73 | 142.3 | 63.06 | 153.43 | 69.31 | 129.21 |
Income Tax Expense | 39.8 | 47.79 | 52.58 | 62.41 | 43.03 | 62.28 |
Earnings From Continuing Operations | 97.93 | 94.51 | 10.47 | 91.02 | 26.28 | 66.93 |
Minority Interest in Earnings | -1.69 | 5.08 | 4.86 | 30.04 | 33.41 | 27.38 |
Net Income | 96.24 | 99.59 | 15.34 | 121.06 | 59.7 | 94.31 |
Net Income to Common | 96.24 | 99.59 | 15.34 | 121.06 | 59.7 | 94.31 |
Net Income Growth | 25.77% | 549.35% | -87.33% | 102.79% | -36.70% | - |
Shares Outstanding (Basic) | 334 | 334 | 334 | 334 | 334 | 334 |
Shares Outstanding (Diluted) | 334 | 334 | 334 | 334 | 334 | 334 |
Shares Change | -0.02% | - | - | - | - | - |
EPS (Basic) | 0.29 | 0.30 | 0.05 | 0.36 | 0.18 | 0.28 |
EPS (Diluted) | 0.29 | 0.30 | 0.05 | 0.36 | 0.18 | 0.28 |
EPS Growth | 25.80% | 549.35% | -87.33% | 102.78% | -36.69% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 232.8 | 234.48 | 193.15 | 73.31 | 106.2 | 162.19 |
Free Cash Flow Per Share | 0.70 | 0.70 | 0.58 | 0.22 | 0.32 | 0.48 |
Dividend Per Share | 0.160 | 0.160 | 0.150 | - | - | - |
Dividend Growth | 6.67% | 6.67% | - | - | - | - |
Gross Margin | 18.61% | 18.23% | 15.66% | 17.84% | 13.28% | 16.63% |
Operating Margin | 8.13% | 7.28% | 1.97% | 5.84% | 1.58% | 6.45% |
Profit Margin | 4.86% | 4.92% | 0.75% | 5.93% | 3.23% | 4.83% |
Free Cash Flow Margin | 11.76% | 11.58% | 9.40% | 3.59% | 5.75% | 8.30% |
EBITDA | 258.94 | 244.89 | 148.07 | 227.19 | 142.83 | 239.62 |
EBITDA Margin | 13.08% | 12.10% | 7.20% | 11.13% | 7.74% | 12.26% |
D&A For EBITDA | 98 | 97.46 | 107.68 | 107.91 | 113.59 | 113.6 |
EBIT | 160.95 | 147.43 | 40.39 | 119.27 | 29.24 | 126.02 |
EBIT Margin | 8.13% | 7.28% | 1.97% | 5.84% | 1.58% | 6.45% |
Effective Tax Rate | 28.90% | 33.58% | 83.39% | 40.67% | 62.08% | 48.20% |